MD : NYSE : Health Care
$65.10 up 0.09 | 0.14%
Today's Range: 64.75 - 65.38
Avg. Daily Volume: 609,800
09/27/16 - 3:59 PM ET

Financial Analysis


MEDNAX INC's gross profit margin for the second quarter of its fiscal year 2016 is essentially unchanged when compared to the same period a year ago. Even though sales increased, the net income has decreased. MEDNAX INC has strong liquidity. Currently, the Quick Ratio is 1.58 which shows the ability to cover short-term cash needs. The company's liquidity has increased from the same period last year, indicating improving cash flow.

During the same period, stockholders' equity ("net worth") has increased by 15.24% from the same quarter last year. The key liquidity measurements indicate that the company is unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q2 FY16 Q2 FY15
Net Sales ($mil)771.76676.59
EBITDA ($mil)168.03156.51
EBIT ($mil)147.79140.96
Net Income ($mil)82.4384.13


Balance Sheet Q2 FY16 Q2 FY15
Cash & Equiv. ($mil)62.4870.43
Total Assets ($mil)4771.414275.14
Total Debt ($mil)1439.451296.9
Equity ($mil)2557.972219.55


Profitability Q2 FY16 Q2 FY15
Gross Profit Margin33.7133.83
EBITDA Margin21.7723.13
Operating Margin19.1520.83
Sales Turnover0.630.61
Return on Assets6.997.65
Return on Equity13.0414.75
Debt Q2 FY16 Q2 FY15
Current Ratio1.651.69
Debt/Capital0.360.37
Interest Expense15.065.15
Interest Coverage9.8127.38


Share Data Q2 FY16 Q2 FY15
Shares outstanding (mil)93.594.03
Div / share0.00.0
EPS0.890.9
Book value / share27.3623.61
Institutional Own % n/a n/a
Avg Daily Volume615307.0670494.0

Valuation


BUY. This stock's P/E ratio indicates a discount compared to an average of 20.69 for the Health Care Providers & Services industry and a discount compared to the S&P 500 average of 25.19. For additional comparison, its price-to-book ratio of 2.41 indicates a discount versus the S&P 500 average of 2.82 and a discount versus the industry average of 3.14. The price-to-sales ratio is above the S&P 500 average and well above the industry average, indicating a premium. Upon assessment of these and other key valuation criteria, MEDNAX INC proves to trade at a discount to investment alternatives within the industry.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
MD 18.42 Peers 20.69   MD 15.70 Peers 12.71

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

MD is trading at a discount to its peers.

 

Premium. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

MD is trading at a premium to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
MD 14.46 Peers 15.78   MD 1.18 Peers 0.85

Average. An average price-to-projected earnings ratio can signify an industry neutral stock price and average future growth expectations.

MD is trading at a valuation on par with its peers.

 

Premium. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

MD trades at a significant premium to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
MD 2.41 Peers 3.14   MD 6.23 Peers 27.83

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

MD is trading at a discount to its peers.

 

Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, MD is expected to significantly trail its peers on the basis of its earnings growth rate.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
MD 2.06 Peers 0.78   MD 15.24 Peers 14.36

Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

MD is trading at a significant premium to its industry.

 

Average. Comparing a company's sales growth to its industry helps to determine if the company is adding or losing market share.

MD is keeping pace with its peers on the basis of sales growth.

 

 

Latest Stock Upgrades/Downgrades